Skip to main content
Livermore
Livermore
ZHEN

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

RLAY holding history

Relay Therapeutics, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RLAY overviewAll 13F holders of RLAYFull Q2 2026 holdings

Shares (Q2 2026)
3,127,564
Value
$58.5M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of RLAY by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,127,564$58.5M<0.1%+187,028+6.4%AddedHolders
Q1 20262,940,536$29.2M<0.1%+460,186+18.6%AddedHolders
Q4 20252,480,350$21.0M<0.1%−2,600−0.1%ReducedHolders
Q3 20252,482,950$13.0M<0.1%−306,510−11.0%ReducedHolders
Q2 20252,789,460$9.65M<0.1%−9,631−0.3%ReducedHolders
Q1 20252,799,091$7.33M<0.1%−165,906−5.6%ReducedHolders
Q4 20242,964,997$12.2M<0.1%+1,216,334+69.6%AddedHolders
Q3 20241,748,663$12.4M<0.1%+228,323+15.0%AddedHolders
Q2 20241,520,340$9.91M<0.1%−80,474−5.0%ReducedHolders
Q1 20241,600,814$13.3M<0.1%+241,659+17.8%AddedHolders
Q4 20231,359,155$15.0M<0.1%+341,487+33.6%AddedHolders
Q3 20231,017,668$8.56M<0.1%−146,718−12.6%ReducedHolders
Q2 20231,164,386$14.6M<0.1%−71,409−5.8%ReducedHolders
Q1 20231,235,795$20.4M<0.1%+177,252+16.7%AddedHolders
Q4 20221,058,543$15.8M<0.1%+422,936+66.5%AddedHolders
Q3 2022635,607$14.2M<0.1%+241,816+61.4%AddedHolders
Q2 2022393,791$6.59M<0.1%+335,925+580.5%AddedHolders
Q1 202257,866$1.73M<0.1%+57,866NewHolders
Q3 20210$00.0%−6,236−100.0%Sold outHolders
Q2 20216,236$228.0K<0.1%00.0%UnchangedHolders
Q1 20216,236$216.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.